Fungal profile and susceptibility pattern in cases of keratomycosis

JK Science

Volumn 8, Issue 1, 2006, Pages 39-41

  Arora, Usha ^a,b   Aggarwal, Aruna ^a   Joshi, Vijay ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

Antifungal agents; Aspergillus; Keratomycosis; Minimum inhibitory concentration (MIC)

Indexed keywords

FLUCONAZOLE; KETOCONAZOLE;

ADOLESCENT; ADULT; AGAR MEDIUM; ALTERNARIA; ARTICLE; ASPERGILLUS; CANDIDA; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA ULCER; CORNEAL BIOPSY; DILUTION; DRUG SENSITIVITY; EYE INJURY; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INCIDENCE; KERATOMYCOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIUM; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33745943963     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chirambo MC, Tielsch JM, West KP. Blindness & visual impairment in Southern Malian. Bull WHO 1986; 64: 567-72.
2. Khan MK, Haque MR, Khan MR. Prevalence and causes of blindness in rural Bangladesh. Ind J Med Res 1985; 82: 257-62.
3. Thylefors B, Negral AD, Segaram PR. Available data on blindness (Update 1994). Ophthalmic Epidemiology 1995; 2: 5-39.
4. Verenkar MP, Subhangi B, Pinto MJW. A study of mycotic keratitis in Goa. Ind J Med Microb 1998; 16: 58-60.
5. Pankjaluxmi V, Taraluxmi V, Gomathi A, Kavarasi S. Mycotic keratitis in Madras. Ind J Pathol Microbiol 1989; 32: 190-97.
6. Ganegoda N, Rao SK. Medical Research Foundation, Naidu, India. Antifungal therapy for keratomycosis. Expert Opin Pharmacother 2004; 5(4): 865-74.
7. Chander J. Routine mycological techniques. Textbook of Medical Mycology, Ed. II, Mehta Publishers, New Delhi, 2002. pp. 391-93.
8. Kotigadde S, Ballal M, Jyothirlath AK. Mycotic keratitis: A study in coastal Karnatka. Ind J Ophthalmol 1992; 40: 31-33.
9. Rahman MR, Minassian DC, Srinivasan M. Trial of Chlorhexidine gluconate for fungal corneal ulcers. Ophthalmic Epidemiology 1997; 4: 141-49.
10. Reddy RP, Shanthi N, Das H. A randomized single blind comparative study of topical fluconazole/natamycin in the treatment of fungal corneal ulcer. Ind J Ophthalmol 1997; 1: 24-25.
11. Bharathi MJ, Ramakrishanan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis; A three year study. Ind J Opthalmol 2003; 51(4),315-21.
12. Kumari N, Xess A, Shahi SK. A study of keratomycosis, our experience. Indian J Pathol Microbiol. 2002; 45(3): 299:302.
13. Poria VC, Bharad VR, Dongre DS. Study of mycotic keratitis. Ind J Ophthalmol 1985; 33: 229-31.
14. Odds FC, Cheesman SL, Abbott AB. Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. J Antimicrob Chemother 1986; 18(4): 473-78.
15. Isabel P, Joan FB, Josep G. Effect of inoculum form on in vitro antifungal susceptibilities of aspergillus species. J Antimicrob Chemother 2001; 47: 715-18.
16. Troke PF, Andrew RJ, Pye GW. Fluconazole and other azoles translation of invitro activity in vivo and clinical efficacy. Rev Infect Dis 1990; 12 (Supp 3) 276-80.